Eli Lilly holds $112.48B in total assets. Shareholders' equity is $26.5B against $41.1B in total debt. Cash and equivalents total $7.3B. The current ratio is 1.58 and debt-to-equity is 1.55. Based on the Q4 2025 filing.
We use cookies for analytics. See our Privacy and Cookie Policy.